Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/175290
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMarsà, Alícia-
dc.contributor.authorAscanio, Meritxell-
dc.contributor.authorDiaz-García, Javier-
dc.contributor.authorDarbà, Josep-
dc.date.accessioned2021-03-17T21:09:55Z-
dc.date.available2021-12-31T06:10:21Z-
dc.date.issued2020-12-
dc.identifier.issn1369-6998-
dc.identifier.urihttp://hdl.handle.net/2445/175290-
dc.description.abstractThis study reviewed patient characteristics, management, and medical costs of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs) in Spanish hospitals.-
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherTaylor and Francis-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1080/13696998.2020.1840180-
dc.relation.ispartofJournal of Medical Economics, 2020, vol. 23, num. 12, p. 1477-1484-
dc.relation.urihttps://doi.org/10.1080/13696998.2020.1840180-
dc.rights(c) Taylor and Francis, 2020-
dc.sourceArticles publicats en revistes (Economia)-
dc.subject.classificationLeucèmia mieloide-
dc.subject.classificationAnàlisi cost-benefici-
dc.subject.classificationGestió hospitalària-
dc.subject.otherMyeloid leukemia-
dc.subject.otherCost effectiveness-
dc.subject.otherHospital administration-
dc.titleEpidemiology, management, and economic impact of acute myeloid leukemia and myelodysplastic syndrome in Spain: a claims database analysis-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec703859-
dc.date.updated2021-03-17T21:09:55Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
703859.pdf602.43 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.